Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
Molecular biomarker testing is the standard of care for non-small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...
Saved in:
Main Authors: | Sunhee Chang (Author), Hyo Sup Shim (Author), Tae Jung Kim (Author), Yoon-La Choi (Author), Wan Seop Kim (Author), Dong Hoon Shin (Author), Lucia Kim (Author), Heae Surng Park (Author), Geon Kook Lee (Author), Chang Hun Lee (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Provisional Guideline Recommendation for Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
by: Dong Hoon Shin, et al.
Published: (2019) -
Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
by: Sungha Park, et al.
Published: (2023) -
Molecular Testing of Lung Cancers
by: Hyo Sup Shim, et al.
Published: (2017) -
Review of Medical Advisory Services by the Korean Society of Pathologists from 2003 to 2014
by: Min Hye Jang, et al.
Published: (2016) -
The results of cardiopulmonary exercise test in healthy Korean children and adolescents: single center study
by: Jun-Sook Lee, et al.
Published: (2013)